William J. Newell
2017
In 2017, William J. Newell earned a total compensation of $702.5K as Chief Executive Officer at SUTRO BIOPHARMA.
Compensation breakdown
Non-Equity Incentive Plan | $199,000 |
---|---|
Salary | $467,620 |
Other | $35,903 |
Total | $702,523 |
Newell received $467.6K in salary, accounting for 67% of the total pay in 2017.
Newell also received $199K in non-equity incentive plan and $35.9K in other compensation.
Rankings
In 2017, William J. Newell's compensation ranked 10,597th out of 14,666 executives tracked by ExecPay. In other words, Newell earned more than 27.7% of executives.
Classification | Ranking | Percentile |
---|---|---|
All | 10,597 out of 14,666 | 28th |
Division Manufacturing | 4,127 out of 5,772 | 29th |
Major group Chemicals And Allied Products | 1,474 out of 2,075 | 29th |
Industry group Drugs | 1,205 out of 1,731 | 30th |
Industry Biological Products, Except Diagnostic Substances | 219 out of 313 | 30th |
Source: SEC filing on April 25, 2019.
Newell's colleagues
We found two more compensation records of executives who worked with William J. Newell at SUTRO BIOPHARMA in 2017.
News
SUTRO BIOPHARMA CEO William Newell's 2021 pay jumps 161% to $5.6M
April 22, 2022
SUTRO BIOPHARMA CEO William Newell's 2020 pay falls 44% to $2.2M
April 29, 2021
SUTRO BIOPHARMA CEO William Newell's 2019 pay falls 56% to $3.8M
April 24, 2020
SUTRO BIOPHARMA CEO William Newell's 2018 pay jumps 1,136% to $8.7M
April 25, 2019